AMGN vs BSX
By Alex · Tickerpine
Amgen Inc. vs Boston Scientific Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | BSX |
|---|---|---|
| Price | $358.33 | $44.23 |
| Market cap | $193.39B | $65.74B |
| P/E ratio | 24.9 | 18.5 |
| ROE | 101.32% | 14.66% |
| Profit margin | 20.96% | 17.29% |
| Revenue growth | 5.80% | 11.60% |
| Dividend yield | 2.81% | — |
| Beta | 0.42 | 0.56 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs BSX in plain English
- AMGN is the bigger company — about 2.9× the market cap of BSX.
- BSX is cheaper on earnings (P/E 18.5 vs 24.9).
- AMGN earns a higher return on equity (101% vs 15%).
- BSX is growing revenue faster (12% vs 6%).
- AMGN pays a dividend (2.81%) while the other effectively doesn't.
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
BSX return calculator
See what $1,000 in Boston Scientific Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.